America’s “tech cash shell” boom
America's tech companies are eschewing going public through an IPO and opting to use “special purpose acquisition companies” (SPACs) – also known as cash shells – instead.

Special purpose acquisition companies (SPACs) – also known as cash shells – have “suddenly become the hottest way to raise capital, especially in tech”, says Kara Swisher in The New York Times. A SPAC raises money through an initial public offering (IPO), then uses the cash to buy a business that wants to list on the stockmarket but doesn’t want to go through the IPO process. As such, they are “essentially a back door to taking a start-up public”.
This appeals to many tech entrepreneurs, who believe that the investment banks that carry out IPOs tend to underprice them, leaving “billions on the table that should go to the companies, and not to Wall Street firms and their clients”. What’s more, most detest the hassle of taking part in an IPO: ”often they compare it to dental implant surgery”. So as the tech sector booms, so do SPACs: there have been 75 new SPAC listings in the US this year, raising more than $30bn.
There is another way to go public without an IPO, notes Yun Li on CNBC: a direct listing, when a firm simply lists its shares on the exchange. The limitation is that it can’t raise new capital at the same time – only existing investors can sell their shares. But last month US regulators approved new rules that will let firms carrying out a direct listing on the New York Stock Exchange and sell new shares on the first day of trading. This “could curb some of the enthusiasm in the booming SPAC market, as it provides similar advantages”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Could a sugar rush protect you from a stock market crash?
Sugar has some defensive qualities during economic downturns, but is now the right time to invest in sugar?
By Dan McEvoy
-
What is Rory McIlroy’s net worth?
Rory McIlroy’s net worth has surged after the Northern Irish golfer won his first Career Grand Slam, earning his place among golf legends. We take a deep dive into his fortune.
By Oojal Dhanjal
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine